About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Front-line Treatment for NSCLC: Is Chemotherapy Here to Stay?
By
Melissa Johnson
3 Videos
1,458 views
January 11, 2019
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
35:40
Balazs Halmos
Year in Review: Lung Cancer
17:20
Total Health
2024 Intervention Selection & Sequencing in Early Stage NSCLC
Feat.
J. Porter
07:31
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Cli…
Feat.
J. West
14:49
Vivek Subbiah
Year in Review: Precision Medicine
08:49
David Carbone
The Use of IO Doublet in PD-L1-Negative NSCLC
23:32
2023 West Oncology Conference
2023 Updates on Neoadjuvant and Adjuvant NSCLC
Feat.
M. Johnson
16:12
Total Health
2024 Updates on the Fast-Changing NSCLC Landscape
Feat.
R. Osarogiagbon
11:50
GRACE
The CheckMate 816 Trial: The Success of Neoadjuvant NSCLC Therapies
Feat.
J. Rotow
54:26
Yale Cancer Center
Year in Review: Progress in NSCLC Treatment
Feat.
R. Herbst
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
20:27
Yale Cancer Center
Progress in the Treatment of NSCLC
Feat.
R. Herbst
08:30
Insights from 2023 ESMO Annual Meeting
PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EG…
Feat.
N. Girard
26:42
Total Health
ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 AS…
Feat.
J. Bauman
17:57
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Expert Discussion on New Treatment Options…
Feat.
D. Carbone,
B. Stiles
08:15
ecancer
ESMO 2023 Summary: "Highlights From Recent NSCLC Trials"
Feat.
B. Gyawali
03:44
ecancer
ASCO® 2023 Insights: "Dr. Wakelee on KEYNOTE-671 Study Updates …
Feat.
H. Wakelee
03:22
ecancer
WCLC 2023 Insights: "Phase 3 FLAURA2 Study - Osimertinib + Chem…
Feat.
P. Janne
09:42
Robert Hsu
Unmet Need in NSCLC Treatment Options Following Progression on 1L IO…
20:28
OncoAlert
mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC
Feat.
C. Aggarwal
